- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04316741
Brief Intervention Combined With Health Coaching Via Social Media for Cannabis Use
December 7, 2022 updated by: Erin Bonar, University of Michigan
Harnessing Social Media to Reduce Cannabis Use Among Adolescents and Emerging Adults in an Urban Emergency Department
The purpose of the study is to develop and test social media interventions to help young people increase well-being and reduce risky behaviors.
The study will help researchers learn about ways to deliver wellness information in a way that is appealing and helpful to young people who use Snapchat.
Study Overview
Study Type
Interventional
Enrollment (Actual)
63
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Flint, Michigan, United States, 48503
- Hurley Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Individuals seen in the Emergency Department at Hurley Medical Center who meet these criteria
- self-report of weekly or more frequent cannabis use for past 3 months
- past month Snapchat use
- ability to consent
- English-speaking
- between ages 18-25
- smart phone ownership
Exclusion Criteria:
- Emergency Department presentation for suicidality and/or acute psychosis, being in police custody, or present with psychological distress requiring intensive social work (e.g. sexual assault)
- having a medical cannabis card
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Brief Intervention+Health Coaching
Brief intervention with social-media delivered health coaching
|
A brief motivational interviewing-based intervention combined with health coaching via social media for 4 weeks
|
No Intervention: Control
Enhanced usual care brochure plus attention control with social media messaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brief Intervention Acceptability
Time Frame: Immediate post-test administered after the session
|
Acceptability rating completed by participants for the brief intervention session
|
Immediate post-test administered after the session
|
Snapchat Acceptability Rating
Time Frame: 1 month
|
Acceptability rating completed by participants for the Snapchat-delivered health coaching. Item: In general, I enjoyed the Snapchat messages from the SnapCoach team. (Not at all, A little, Somewhat, Very, Extremely) |
1 month
|
Brief Intervention Feasibility
Time Frame: Immediate
|
% of participants assigned to condition who complete the brief intervention
|
Immediate
|
Snapchat Health Coaching Feasibility
Time Frame: Up to 1 month
|
% of participants who complete key activities (e.g., % who add health coach on Snapchat)
|
Up to 1 month
|
Snapchat Health Coaching Feasibility
Time Frame: Up to 1 month
|
% of participants who complete key activities (e.g., % who reply to at least 1 Snapchat message)
|
Up to 1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Erin Bonar, University of Michigan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 19, 2020
Primary Completion (Actual)
February 21, 2022
Study Completion (Actual)
February 21, 2022
Study Registration Dates
First Submitted
March 19, 2020
First Submitted That Met QC Criteria
March 19, 2020
First Posted (Actual)
March 20, 2020
Study Record Updates
Last Update Posted (Actual)
December 30, 2022
Last Update Submitted That Met QC Criteria
December 7, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00139068
- R34DA045712 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis Use
-
Centre hospitalier de l'Université de Montréal...RecruitingCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
The University of Tennessee, KnoxvilleColorado State UniversityActive, not recruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Elias DakwarRecruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
Oregon Research InstituteCompletedCannabis Use Disorder, Mild | Cannabis Use Disorder, ModerateUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Food and Drug Administration (FDA)Not yet recruitingTobacco Use | Cannabis | Cannabis Use | Vaping | THC | Cannabis SmokingUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingBipolar Disorder | Cannabis Use | Bipolar I Disorder | Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe | Bipolar II Disorder | Schizoaffective Disorder, Bipolar TypeUnited States
-
Hartford HospitalYale UniversityNot yet recruitingMarijuana Use | Cannabis Use | Cannabis Intoxication
-
McMaster UniversityCenter for Medicinal Cannabis ResearchNot yet recruitingCannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe